Peptides in the Air: Advancing Respiratory Disease Diagnosis Through Breath Analysis

July 31, 2025

What’s Trending

A hot trend in the peptide and diagnostic field is the development of noninvasive, peptide-based biosensors for real-time disease detection. Among these, using engineered peptide substrates to detect protease activity in human breath is emerging as a novel diagnostic strategy.

This approach addresses the growing demand for rapid, accurate, and patient-friendly diagnostic tools, especially in critical care settings. Breath-based diagnostics, combined with synthetic peptide substrates, offer a promising frontier for identifying infection-related biomarkers without the need for invasive procedures or slow culture methods.

Custom peptide production and analytical GMP manufacturing expertise from CPC Scientific

Research Spotlight

A recent study exemplifies this innovation by introducing an in vitro assay that uses a specific peptide sensor for human neutrophil elastase (HNE), a protease linked to lower respiratory tract infections (LRTIs). Researchers developed a sensitive breath collection system and demonstrated that HNE activity, measured via the peptide sensor, was significantly elevated in intubated patients with LRTIs. The assay showed exceptional diagnostic performance with an AUC of 0.987, 100% sensitivity, and 86.7% specificity.

This proof-of-concept highlights how peptide-based sensors can transform breath into a viable, noninvasive diagnostic medium, opening the door to faster, more precise detection of bacterial infections in clinical settings.

CPC Scientific’s Role

To enable this cutting-edge research, CPC Scientific synthesized the custom HNE substrate sensor used in the assay: PEG36-Nle(O-Bzl)-Met(O)₂-Oic-Abu-ACC. Delivered at high quality, this peptide sensor was essential to achieving the high sensitivity and specificity of the diagnostic platform, underscoring our capabilities in supporting advanced peptide-based diagnostic development.

  • Chen, D., Mirski, M. A., Chen, S., Bryden, W. A., McLoughlin, M., Kiser, K. M., Caton, E. R., Haddaway, C. R., Cetta, M. S., & Pan, Y. PNAS nexus (2024), 3(9).

    PEG36-Nle(O-Bzl)-Met(O)2-Oic-Abu-ACC was designed in house and synthesized by CPC Scientific Inc (San Jose, CA, Fig. S1). Amino-PEG36-acid (CAS: 196936-04-6) and 2-(7-amino-2-oxochromen-4-yl)acetamide (CAS:296236-23-2) were used for the synthesis. The synthesized sensor was resuspended in high-performance liquid chromatography (HPLC)-grade water with a concentration of 200 µM.

Partner with CPC Scientific

CPC Scientific is one of the premier peptide manufacturer CDMOs in the world. We offer custom linker design and PEGylation services to meet your unique peptide needs, providing tailored solutions with unmatched precision and quality. Get in touch today to learn how our experts can support your programs.

Latest News & Resources

Related Posts & Resources

  • CPC Scientific is one of the premier custom peptide producers in the world and we are proud to offer consistently reliable, high-quality peptides directly to researchers. We can perform virtually any peptide modification, producing peptides from 2 to >200 AAs at purities from 80% up to 99%...

  • PEGylation is now a well-established technique in the field of targeted drug delivery systems. As PEGylated agents receive FDA approval, attention has been given to site-specific PEGylation of PEG chains. CPC Scientific can perform site-specific PEGylation at a variety of sites on peptides...

Latest News & Resources from CPC Scientific

Sign up for CPC Scientific’s newsletter